CPY Document Title - Food and Drug Administration...11743-0568 Headguarters (assembly of submission)...
Transcript of CPY Document Title - Food and Drug Administration...11743-0568 Headguarters (assembly of submission)...
NEO-FRADIN; Neomycin Sulfate Oral Solution USP 60 mL (2 fl. oz)
VIAL LABEL - 60 mL (2fl. oz)
rr..-T.=-.i~-~~-~-.,"'~'--~ -"~=-.:-~-1=..=-""!""~'~'" ",,.,;'\_~ --~'==c:_r-"'.1~.o~-'~'" ~~"'.T ;i'~+"3i.-.:,,.. "=i~"'-',, 814697 000 'NDC 39822-0330-2 ' . ~2 OZ NEO.FRADIN ORAL SOLUTION 4.5 x 1.5
, IIII~IIIII~ IIIIII1 ~3 39822-0330-2 ~Manulacturedfor
~~inc. ~HlIlinglon,llY1143.0568
60 mL(z II. oz.) 0
~!2-Fradi~Neomycin Sulfate Oral Solution 'Ø
USUAL DOSAGE: See package insert forcomplete product Information,
DIspense in tight, light-resistant containers.Store at controlled room temperature
15' to 3D' C (59' to 86' F)Each 5 mL (one teaspoonful) contains:
Neomycin Sulfate 125 mg(equivalent to 87.5 mg neomycin)
Contains FD & C Yellow NO.6(sunset yellow) as a color additive.
125 mg per 5 mL
(pms 354
(
.1 4 n
( NEO-FRADIN; Neomycin Sulfate Oral Solution USP 120 mL (4 fl. oz)
VIAL LABEL - 120 mL (4 fl. oz)
4 OZ NEO.FRADIN ORAL SOLUTION 45 x 225f ~ ~..,.i-=t-o=.",l"' i. . "_~''''''L''~ .y '\"#-;:~::':. ~""""-~'''-.7- '::':'l, .'ri..-~~.f_. f.P\; T'J . ...=_"'_..."' ~i, ." .-e...."._~:L~(;t 814697000, -" NDC 39822-0330-4. - ~tfl-A~'-""~' :...,....~_~ '~...".."",:.~~':_....h ".w.~...... ~ ,.'c"._~.._"'1- "'-""~,'7 _&"~'",.,_".--.~~_ ~~'"~.~."'_~. .;,;;
(
_ 120 mL (4 II. OZ.) USUAL DOSAGE: See
~. ~.. Neo-Fradi-n package
insert for complete~ ò product Information.¡:. Oral Solution Dispense In tight,c; ,,.. light-resIstant containers.
(' = ~.O Neomycin Sulfate Oral Solution USP Store at controlled room temperature
N - "'I 15't030'C(59't086'F):: ~. Each 5 mL (one teaspoonful)--. contains:-- z", Neomycin Sulfate 125 mg:: D (equivalent to 87.5 mg neomycin)Manufactured for: i.~ om ContaIns FD & C Yellow
c; Y NO.6 (sunset yellow) as aPharma.Tek, Inc. HunUngtoo 'LY, 11743-0568. . g:h r- p color additive._ Q)una~ 3 ',.
~~~~.~, ---"-~~~,;.. . .-_..~..,_.-pms 354
\
1 r-' l."¡:~. d
'k.
r --) 1.Pharma-Tekleomycin Sulfate Oral Solution USP, 125 mg/5 mL Rev. NO.1ANDA 65-010
2 . ANDA # 65 - 010
3. NAME AND ADDRESS OF APPLICANTPharma-Tek Inc.P .0. Box 1920Huntington, NY11743-0568
Headguarters (assembly of submission)Pharma-Tek Inc.P.O. Box 1920Huntington, NY11743 - 0568
Attention: Susan E. BadiaTel. : 516-757-5522Fax: 5 1 6 - 754 - 155 0
"I,
)
Distributor:Pharma-Tek Inc.744 Baldwin St.Elmira, NY 14901
Contact person: J. Robin Liles, Director of OperationsTel. : 607-732-5555Fax: 6 0 7 - 732 - 4 3 82
Manufacturing Facility:i
i
I
i,
)
4. LEGAL BASIS for ANDA SUBMISSION:Pharma-Tek has been distributing this product under privatelabel for the innovator firm under contract since 1996.Recently the innovator, Pharmacia-Upj ohn, discontinuedproduction and sale of the product. Pharma-Tek purchàsed theapplication and excess inventory from innovator and thisapplication is for drug product identical in formulation toinnovator N50-285.
'.